This quarter, the NIC was joined by NIC members from ChristianaCare and Stony Brook Medicine to share how their organizations used different strategies to increase DERS compliance.
Originally aired Wednesday, September 17, 2025
Dose error reduction software (DERS) compliance is a key indicator of how often infusions are programmed within the drug library of smart infusion pumps. Best practice guidelines recommend a goal DERS compliance of 95% or greater to ensure the safest delivery of intravenous medications to patients.
ChristianaCare and Stony Brook Medical Center have been successful in improving their DERS compliance through a combination of novel mechanisms and multidisciplinary engagement.
This quarter, the NIC will be joined by Maha O. Kebir, PharmD, MS, BCPS, CPHQ, CPPS, and Dean A. Bennett, RPh, CPHQ, LSSGB from ChristianaCare to share their use of RFID technology to drive improvement in DERS compliance. In addition, Randi Trope, DO, MBA, CMSO, FAAP from Stony Brook Medicine will share how her organization used unit-specific identifiers to increase DERS compliance.
Slides:
Access Meeting Slides Here
.
Featured Speakers
|

Randi Trope, DO, MBA, CMSO, FAAP
Vice-Chair, Pediatric Quality and Safety Pediatric Medical Director of Patient Safety
Stony Brook Children’s Hospital
|

Maha O. Kebir, PharmD, MS, BCPS, CPHQ, CPPS
Clinical Pharmacist Specialist and Quality and Performance Improvement
ChristianaCare
|

Dean A. Bennett, RPh, CPHQ, LSSGB
Medication Safety Officer, Clinical Effectiveness Administration
ChristianaCare
|
Hosts
|

Sean O'Neill, Pharm.D
Co-Chair, National Infusion Collaborative
Co-Founder, Bainbridge Health
|

Joanne Hatfield, Pharm.D, BCPS
Co-Chair, National Infusion Collaborative
Director of Clinical Solutions, Bainbridge Health
|